DRKS00021024
Recruiting
Not Applicable
Register for Cardiovascular Events under new cancer Therapies - RECENT
niversitätsklinikum KölnKlinik III für Innere Medizin0 sites200 target enrollmentNovember 19, 2021
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Chronic lymphocytic leukemiaMantle cell lymphomaHodgkin-LymphomaRenal cell carcinomaSquamous cell carcinoma of the head and neck areaMalignant melanoma
- Sponsor
- niversitätsklinikum KölnKlinik III für Innere Medizin
- Enrollment
- 200
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients prior to initiation of a therapy with a checkpoint inhibitor for the treatment of a malignant disease
- •Patients prior to initiation of a therapy or under therapy with a BTK inhibitor for the treatment of a malignant disease
- •Patients prior to initiation of a therapy with the combination of BRAF and MEK inhibitors for the treatment of a malignant disease
- •Age\> 18 years
- •Educational ability: The patient must be able to understand and to sign the declaration of consent. He must be sufficiently proficient in the German language.
Exclusion Criteria
- •Lack of consent
- •Pregnant or breastfeeding women
- •Patient depending on or in relation to the sponsor or PI
- •Life expectancy \<12 months due to illness
- •Patients unable to give informed consent
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Project on the promotion of cardiovascular risk evaluation in clinical practice and the assessment of cardiovascular risk evolution after the introduction of a preventive multifactorial strategy aimed at decresing the global risk level (SCORE algorithm), in subjects affected from metabolic syndrome and with a risk level lt; or = 5%Methabolic syndrome (preventive multifactorial strategy aimed at decresing the global risk level) in patients with a risk level ltor = 5%MedDRA version: 6.1Level: PTClassification code 10052066EUCTR2004-000829-30-ITOVARTIS FARMA
Completed
Not Applicable
nited Kingdom Pacing And Cardiovascular Events studyAtrioventricular conduction blockCirculatory SystemISRCTN37445539Medical Research Council (MRC) (UK)2,000
Not yet recruiting
Not Applicable
A Heart Health check for Maori and Pacific People in HospitalCardiovascular diseaseCardiovascular - Coronary heart diseaseStroke - IschaemicPublic Health - Health service researchACTRN12624000920594Christchurch Hospital Pharmacy Department200
Active, not recruiting
Phase 1
CREATE. Cardiovascular Risk Evaluation and Attenuation of inflammation by early rosuvastatin TrEatment - CREATEEUCTR2006-001860-22-ISKarl Andersen
Recruiting
Not Applicable
trecht Cardiovascular Cohort - The Second Manifestations of ARTerial disease StudyMyocardial infarctionStrokeVascular disease10003216NL-OMON54646niversitair Medisch Centrum Utrecht16,227